159 related articles for article (PubMed ID: 35834528)
1. A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection.
Wobeser WL; McBane JE; Balfour L; Conway B; Gill MJ; Huff H; Kilby DLP; Fergusson DA; Mallick R; Mills EJ; Muldoon KA; Rachlis A; Ralph ED; Rosenes R; Singer J; Singhal N; Tan D; Tremblay N; Vo D; Walmsley SL; Cameron DW;
PLoS One; 2022; 17(7):e0270590. PubMed ID: 35834528
[TBL] [Abstract][Full Text] [Related]
2. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial.
Baum MK; Campa A; Lai S; Sales Martinez S; Tsalaile L; Burns P; Farahani M; Li Y; van Widenfelt E; Page JB; Bussmann H; Fawzi WW; Moyo S; Makhema J; Thior I; Essex M; Marlink R
JAMA; 2013 Nov; 310(20):2154-63. PubMed ID: 24281460
[TBL] [Abstract][Full Text] [Related]
3. Micronutrient supplementation in adults with HIV infection.
Visser ME; Durao S; Sinclair D; Irlam JH; Siegfried N
Cochrane Database Syst Rev; 2017 May; 5(5):CD003650. PubMed ID: 28518221
[TBL] [Abstract][Full Text] [Related]
4. Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection.
Singhal N; Fergusson D; Huff H; Mills EJ; la Porte C; Walmsley S; Cameron DW
Contemp Clin Trials; 2010 Nov; 31(6):604-11. PubMed ID: 20708714
[TBL] [Abstract][Full Text] [Related]
5. Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV.
Balfour L; Spaans JN; Fergusson D; Huff H; Mills EJ; la Porte CJ; Walmsley S; Singhal N; Rosenes R; Tremblay N; Gill MJ; Loemba H; Conway B; Rachlis A; Ralph E; Loutfy M; Mallick R; Moorhouse R; William Cameron D
PLoS One; 2014; 9(1):e85607. PubMed ID: 24465617
[TBL] [Abstract][Full Text] [Related]
6. Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial.
Kamwesiga J; Mutabazi V; Kayumba J; Tayari JC; Uwimbabazi JC; Batanage G; Uwera G; Baziruwiha M; Ntizimira C; Murebwayire A; Haguma JP; Nyiransabimana J; Nzabandora JB; Nzamwita P; Mukazayire E;
AIDS; 2015 Jun; 29(9):1045-52. PubMed ID: 25870994
[TBL] [Abstract][Full Text] [Related]
7. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
[TBL] [Abstract][Full Text] [Related]
8. Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial.
Isanaka S; Mugusi F; Hawkins C; Spiegelman D; Okuma J; Aboud S; Guerino C; Fawzi WW
JAMA; 2012 Oct; 308(15):1535-44. PubMed ID: 23073950
[TBL] [Abstract][Full Text] [Related]
9. Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial.
Kasang C; Kalluvya S; Majinge C; Kongola G; Mlewa M; Massawe I; Kabyemera R; Magambo K; Ulmer A; Klinker H; Gschmack E; Horn A; Koutsilieri E; Preiser W; Hofmann D; Hain J; Müller A; Dölken L; Weissbrich B; Rethwilm A; Stich A; Scheller C
PLoS One; 2016; 11(1):e0146678. PubMed ID: 26812052
[TBL] [Abstract][Full Text] [Related]
10. Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial.
Kamwesiga J; Mutabazi V; Kayumba J; Tayari JC; Smyth R; Fay H; Umurerwa A; Baziruwiha M; Ntizimira C; Murebwayire A; Haguma JP; Nyiransabimana J; Habarurema D; Mukarukundo V; Nzabandora JB; Nzamwita P; Mukazayire E; Mills EJ; Seely D; McCready DJ; Warren D
Trials; 2011 Aug; 12():192. PubMed ID: 21838913
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trial.
Twinomujuni SS; Atukunda EC; Mukonzo JK; Nicholas M; Roelofsen F; Ogwang PE
AIDS Res Ther; 2024 Apr; 21(1):22. PubMed ID: 38627722
[TBL] [Abstract][Full Text] [Related]
12. The effect of standard dose multivitamin supplementation on disease progression in HIV-infected adults initiating HAART: a randomized double blind placebo-controlled trial in Uganda.
Guwatudde D; Wang M; Ezeamama AE; Bagenda D; Kyeyune R; Wamani H; Manabe YC; Fawzi WW
BMC Infect Dis; 2015 Aug; 15():348. PubMed ID: 26285704
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
[TBL] [Abstract][Full Text] [Related]
14. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial.
Kaiser JD; Campa AM; Ondercin JP; Leoung GS; Pless RF; Baum MK
J Acquir Immune Defic Syndr; 2006 Aug; 42(5):523-8. PubMed ID: 16868496
[TBL] [Abstract][Full Text] [Related]
15. Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial.
; Filteau S; PrayGod G; Kasonka L; Woodd S; Rehman AM; Chisenga M; Siame J; Koethe JR; Changalucha J; Michael D; Kidola J; Manno D; Larke N; Yilma D; Heimburger DC; Friis H; Kelly P
BMC Med; 2015 Jan; 13():17. PubMed ID: 25630368
[TBL] [Abstract][Full Text] [Related]
16. Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial.
Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Coleman SM; Doyle MF; Yaroslavtseva T; Bridden C; So-Armah K; Tracy R; Bryant K; Lioznov D; Krupitsky E; Samet JH
JAMA Netw Open; 2020 May; 3(5):e204330. PubMed ID: 32383748
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.
ENCORE1 Study Group
Lancet; 2014 Apr; 383(9927):1474-1482. PubMed ID: 24522178
[TBL] [Abstract][Full Text] [Related]
18. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.
Babiker AG; Emery S; Fätkenheuer G; Gordin FM; Grund B; Lundgren JD; Neaton JD; Pett SL; Phillips A; Touloumi G; Vjechaj MJ;
Clin Trials; 2013; 10(1 Suppl):S5-S36. PubMed ID: 22547421
[TBL] [Abstract][Full Text] [Related]
19. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.
Baum MK; Lai S; Sales S; Page JB; Campa A
Clin Infect Dis; 2010 Jun; 50(12):1653-60. PubMed ID: 20455705
[TBL] [Abstract][Full Text] [Related]
20. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
